an analysis of shared treatment decision-making in patients with r/r dlbcl
Published 2 years ago • 312 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
1:47
shared treatment decision-making
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
10:08
analysis of heterogeneity of treatment effects with causal forests using the grf package in r
-
26:35
average treatment effects: confounding
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
1:18
estimating long-term outcomes in patients with chl using an oncology simulation model
-
7:30
updates from juliet: correlative analyses and clinical characteristics associated with efficacy
-
0:56
patient-reported outcomes explored in the beat aml trial
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:30
cardiovascular risk factors and pulmonary hypertension in patients with mpns
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml